Cardiovascular physiology

DAXOR CORPORATION TO EXHIBIT AT THE SOCIETY FOR CRITICAL CARE MEDICINE 50TH CONGRESS VIRTUAL EVENT

Retrieved on: 
Tuesday, January 26, 2021
Branches of biology, Anatomy, Hematology, Body fluids, Blood volume, Cardiovascular physiology, Blood test, Blood, Transfusion medicine

Research from the University of Hawaii - John A. Burns School of Medicine relating to the use of Daxors BVA-100 (Blood Volume Analyzer) diagnostic blood test in critical care use is scheduled to be presented.

Key Points: 
  • Research from the University of Hawaii - John A. Burns School of Medicine relating to the use of Daxors BVA-100 (Blood Volume Analyzer) diagnostic blood test in critical care use is scheduled to be presented.
  • We look forward to sharing with leaders new data on how precise, individualized fluid management can lead to better patient outcomes.
  • Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation.
  • Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Argos Cardiac Output Monitor Earns CE Mark Approval

Retrieved on: 
Thursday, January 21, 2021
Medical specialties, Branches of biology, Medicine, Intensive care medicine, Cardiac output, Cardiovascular physiology, Monitoring, Heart, Zemel

VALHALLA, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Retia Medical, a leading provider of minimally-invasive hemodynamic monitoring technology today announced it received CE (Conformit Europenne) Mark approval for its Argos Cardiac Output Monitor.

Key Points: 
  • VALHALLA, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Retia Medical, a leading provider of minimally-invasive hemodynamic monitoring technology today announced it received CE (Conformit Europenne) Mark approval for its Argos Cardiac Output Monitor.
  • Retia's CEO Marc Zemel stated, "Obtaining the CE mark for the Argos Cardiac Output Monitor is a significant corporate milestone and a testament to the quality of the Argos Monitor and to Retias compliance with all applicable European health, safety, performance and environmental requirements."
  • Retias Multi-Beat Analysis (MBA) algorithm offers consistently accurate cardiac output measurements by analyzing multiple heartbeats for each cardiac output calculation.
  • A simple setup requiring only one interconnect cable to attach the Argos to the existing bedside monitor making it the easiest-to-use cardiac output monitor on the market.

Valencell Expands World's First Calibration-Free, Cuffless Blood Pressure Monitoring System to the Finger and Wrist

Retrieved on: 
Tuesday, January 12, 2021
Medicine, Medical specialties, Branches of biology, Cardiovascular physiology, Wearable devices, Medical monitoring, Ubiquitous computing, Wearable computers, Pulse oximetry, Monitoring, Smartwatch, Blood pressure

This latest advancement significantly expands the number of device form factors to embed the technology, including smartwatches, fitness bands, patches and pulse oximeter finger clips.

Key Points: 
  • This latest advancement significantly expands the number of device form factors to embed the technology, including smartwatches, fitness bands, patches and pulse oximeter finger clips.
  • "Huge opportunities exist to ease the burden of blood pressure monitoring and reduce the cost of healthcare with non-invasive sensor technology embedded in devices people wear every day.
  • Highlights include:
    Inconsistent monitoring: People with high blood pressure are not measuring often enough.
  • The 2020 Blood Pressure Research Survey was conducted by Valencell from November 5-9, 2020.

GBT Continues Research on AI Detection System

Retrieved on: 
Thursday, January 7, 2021
Angiology, Artery, Cardiovascular physiology

SAN DIEGO, Jan. 07, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK:GTCH) ("GBT, or the Company), announced that its joint venture, GBT Tokenize Corp. (GBT/Tokenize), is continuing with its research associated with an AI system to detect and open clogs within arteries based on its proprietaryradio technology,which has an internal code name of Hermes.

Key Points: 
  • SAN DIEGO, Jan. 07, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK:GTCH) ("GBT, or the Company), announced that its joint venture, GBT Tokenize Corp. (GBT/Tokenize), is continuing with its research associated with an AI system to detect and open clogs within arteries based on its proprietaryradio technology,which has an internal code name of Hermes.
  • The research is evaluating a system targeted for arterial clogs cleaning, such as a coronary artery, peripheral artery, or any other body vascular organ.
  • The research is evaluating whether the unit can use AI based and radio frequency imaging system to "see" within arteries.
  • GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology.

Capsule and Retia Medical Collaborate on Argos Cardiac Monitor to Streamline Device Interoperability, Protect Patient Safety

Retrieved on: 
Tuesday, January 5, 2021
Sainsbury's, Cardiac output, Cardiovascular physiology, Cardiac monitoring, Argos, Argos, DDI, Spacecraft

and VALHALLA, N.Y., Jan. 5, 2021 /PRNewswire/ --Retia Medical is the first company to utilize Capsule Technologies' new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today.

Key Points: 
  • and VALHALLA, N.Y., Jan. 5, 2021 /PRNewswire/ --Retia Medical is the first company to utilize Capsule Technologies' new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today.
  • "Medical devices, such as Retia Medical's Argos Cardiac Monitor, are indispensable for delivering safe and high-quality patient care," said John McHutcheon, vice president of operations at Capsule Technologies.
  • By leveraging the new DDI development strategy, Retia Medical expedited the integration of its updated Argos Cardiac Monitor, saving engineering time and improving customer satisfaction.
  • Retia Medical's Argos Monitor, with its Multi-Beat Analysis (MBATM) algorithm, eliminates a critical problem with older cardiac output technologies.

Capsule and Retia Medical Collaborate on Argos Cardiac Monitor to Streamline Device Interoperability, Protect Patient Safety

Retrieved on: 
Tuesday, January 5, 2021
Cardiac electrophysiology, Cardiovascular physiology, Cardiac output, Cardiac monitoring, Argos, Argos, DDI, Spacecraft

and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule Technologies new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today.

Key Points: 
  • and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule Technologies new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today.
  • Medical devices, such as Retia Medicals Argos Cardiac Monitor, are indispensable for delivering safe and high-quality patient care, said John McHutcheon, Vice President of Operations of Capsule Technologies.
  • By leveraging the new DDI development strategy, Retia Medical expedited the integration of its updated Argos Cardiac Monitor, saving engineering time and improving customer satisfaction.
  • Retia Medicals Argos Monitor, with its Multi-Beat Analysis (MBA) algorithm, eliminates a critical problem with older cardiac output technologies.

Large-Scale Clinical Study Validates Biospectal's OptiBP™ Generates Blood Pressure Measurements Equivalent to the Traditional Blood Pressure Cuff

Retrieved on: 
Wednesday, December 23, 2020
Branches of biology, Cardiovascular physiology, Blood pressure measurement, Sphygmomanometer, Blood pressure, Non-invasive procedure

Results revealed Biospectal's new cuffless, non-invasive optical approach to blood pressure measurement achieved performance equivalent to that of a traditional blood pressure cuff.

Key Points: 
  • Results revealed Biospectal's new cuffless, non-invasive optical approach to blood pressure measurement achieved performance equivalent to that of a traditional blood pressure cuff.
  • "The traditional blood pressure cuff design hasn't changed in 100+ years.
  • "We view OptiBP as a clear case of disruption of an old paradigm of the blood pressure cuff.
  • Biospectal's OptiBP smartphone application and data platform remove the outdated blood pressure cuff barrier and enables frequent and intelligent blood pressure tracking via a fingertip applied to a smartphone camera lens.

SEC Issues Substituted Compliance Order for Germany and Notice of Substituted Compliance Application and Proposed Substituted Compliance Order for France

Retrieved on: 
Tuesday, December 22, 2020
Cardiovascular physiology, Compliance, Respiratory physiology, Federal Financial Supervisory Authority, Swap, Hester Peirce, Government

First, the Commission is publishing a final substituted compliance order in response to an application by Germanys Bundesanstalt fr Finanzdienstleistungsaufsicht (BaFin).

Key Points: 
  • First, the Commission is publishing a final substituted compliance order in response to an application by Germanys Bundesanstalt fr Finanzdienstleistungsaufsicht (BaFin).
  • In addition, the Commission is publishing a notice of application and proposed substituted compliance order in response to an application by Frances Autorit des Marchs Financiers (AMF) and Autorit de Contrle Prudential et de Rsolution (ACPR).
  • The French application similarly seeks substituted compliance for French security-based swap entities based on compliance with French and EU requirements.
  • Substituted compliance is a critical component to the workable yet effective regulation of the global OTC derivatives markets, said SEC Commissioner Hester Peirce.

NYC 'Vein Queen' Joins Growing NJ and NYC Practice

Retrieved on: 
Monday, December 21, 2020
Medical specialties, Medicine, Surgical specialties, Cardiovascular physiology, Veins, Telangiectasia, Vascular surgery

CLIFTON, N.J., Dec. 21, 2020 /PRNewswire-PRWeb/ --Vein Specialist Centers announced today that a pioneer for the ground-breaking treatment of spider veins has joined its multi-location practice.

Key Points: 
  • CLIFTON, N.J., Dec. 21, 2020 /PRNewswire-PRWeb/ --Vein Specialist Centers announced today that a pioneer for the ground-breaking treatment of spider veins has joined its multi-location practice.
  • As a result, the media crowned her the "Vein Queen" during its coverage of the breakthrough medical advancement.
  • The practice's outstanding team of board-certified, Ivy League-trained physicians, which includes vascular surgeons and cardiovascular surgeons, have built a growing practice that truly puts patients' needs first.
  • Their attention to every detail has earned high satisfaction ratings in the Greater New York region for the practice.

Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.

Retrieved on: 
Thursday, December 10, 2020
Blood tests, Branches of biology, Cardiovascular physiology, Intravascular volume status, Blood volume, Food and Drug Administration, Medicine

A medical center in the Midwest purchased the BVA-100 analyzer for use in their outpatient heart failure clinic.

Key Points: 
  • A medical center in the Midwest purchased the BVA-100 analyzer for use in their outpatient heart failure clinic.
  • We are encouraged by the continued growth and implementation of our market-leading, FDA-cleared diagnostic blood volume test as a new measure of care.
  • Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation.
  • We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms.